These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10365287

  • 1. The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease.
    Linder R, Oldgren J, Egberg N, Grip L, Larson G, Siegbahn A, Wallentin L.
    Eur Heart J; 1999 Apr; 20(7):506-18. PubMed ID: 10365287
    [Abstract] [Full Text] [Related]

  • 2. A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group.
    Eur Heart J; 1997 Sep; 18(9):1416-25. PubMed ID: 9458447
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Thrombin inhibition with inogatran for unstable angina pectoris: evidence for reactivated ischaemia after cessation of short-term treatment.
    Andersen K, Dellborg M, Emanuelsson H, Grip L, Swedberg K.
    Coron Artery Dis; 1996 Sep; 7(9):673-81. PubMed ID: 8950498
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
    Oldgren J, Siegbahn A, Grip L, Linder R, Thygesen K, Wallentin L.
    Thromb Haemost; 2004 Feb; 91(2):381-7. PubMed ID: 14961168
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Heparin is more effective than inogatran, a low-molecular weight thrombin inhibitor in suppressing ischemia and recurrent angina in unstable coronary disease. Thrombin Inhibition in Myocardial Ischemia (TRIM) Study Group.
    Andersen K, Dellborg M.
    Am J Cardiol; 1998 Apr 15; 81(8):939-44. PubMed ID: 9576150
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A, Casilli F, Assanelli E, Grazi M, Marenzi G, Guazzi MD.
    Thromb Haemost; 2001 Oct 15; 86(4):991-4. PubMed ID: 11686357
    [Abstract] [Full Text] [Related]

  • 11. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
    Gold HK, Torres FW, Garabedian HD, Werner W, Jang IK, Khan A, Hagstrom JN, Yasuda T, Leinbach RC, Newell JB.
    J Am Coll Cardiol; 1993 Apr 15; 21(5):1039-47. PubMed ID: 8459055
    [Abstract] [Full Text] [Related]

  • 12. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD, St Pierre A, Leblond L, Deschenes I, DiMaio J, Winocour PD.
    Thromb Haemost; 1998 Feb 15; 79(2):431-8. PubMed ID: 9493603
    [Abstract] [Full Text] [Related]

  • 13. Aspirin does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysis.
    Chen LY, Nichols WW, Mattsson C, Teger-Nilson AC, Wallin R, Saldeen TG, Mehta JL.
    Cardiovasc Res; 1995 Dec 15; 30(6):866-74. PubMed ID: 8746200
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inogatran, a novel direct low molecular weight thrombin inhibitor, given with, but not after, tissue-plasminogen activator, improves thrombolysis.
    Chen L, Nichols WW, Mattsson C, Teger-Nilsson AC, Saldeen TG, Mehta JL.
    J Pharmacol Exp Ther; 1996 Jun 15; 277(3):1276-83. PubMed ID: 8667188
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potential.
    Becker RC, Spencer FA, Li Y, Ball SP, Ma Y, Hurley T, Hebert J.
    J Am Coll Cardiol; 1999 Oct 15; 34(4):1020-7. PubMed ID: 10520784
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
    Mombelli G, Marchetti O, Haeberli A, Straub PW.
    Am Heart J; 1998 Dec 15; 136(6):1106-13. PubMed ID: 9842027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.